Collagen synthesis in dermal fibroblasts

Collagen synthesis in dermal fibroblasts is the process by which fibroblast cells in the skin produce collagen, especially type I collagen, which forms the bulk of the extracellular matrix and provides mechanical support, strength, and elasticity to the skin. This process is regulated by various cellular signals, growth factors (e.g., TGF-β, IGF-1), and mechanical stress. Stimulation of collagen synthesis can be achieved through bioactive compounds, peptides, growth factors, or mechanical interventions (such as hyaluronic acid fillers). Decreased collagen production or increased degradation leads to aging and skin disorders, while enhanced synthesis is targeted by anti-aging and wound healing therapies. The regulation of this process involves complex signaling networks including ERK1/2, AMPK, and integrin-mediated mechanical sensing, and is marked by biochemical changes such as increased COL1A1 expression and procollagen peptide presence.

Other names

Type I collagenCOL1A1collagen biosynthesis

Activation of transcription factors and signaling pathways (such as ERK1/2, AMPK) to increase COL1A1 transcription and translation. Induction of fibroblast stretching or mechanical stress, which stimulates collagen synthesis through integrin receptor signaling. Suppression of collagen-degrading enzymes (matrix metalloproteinases, MMPs) to preserve new collagen. Modulation of growth factor signaling cascades (e.g., TGF-β).